key: cord-1046492-klpaudzt authors: Printz, Carrie title: Research shows racial disparity, mortality data for patients with cancer and COVID‐19 date: 2021-01-12 journal: Cancer DOI: 10.1002/cncr.33429 sha: 9148c26dde6ebec7261d7fe8e88ba90fd0754718 doc_id: 1046492 cord_uid: klpaudzt nan Meanwhile, remdesivir, primarily used in a clinical trial setting, was associated in the RECOVERY trial results with a lower mortality rate in comparison with any other potential COVID-19 treatment; however, Black patients were half as likely as White patients to receive it. Dr. Warner notes that Black patients were likely underrepresented for nonclinical factors. These findings call attention to a pressing need to address these disparities because Black patients and other people of color have been much more heavily affected by the pandemic. In the initial CCC19 study of 928 patients, the mortality rate for patients with cancer who were also diagnosed with COVID-19 was 13%. In this second study of 2186 patients, the rate was 16%. Additional findings showed that West Coast patients were more likely to have received remdesivir and less likely to have taken hydroxychloroquine, which has been demonstrated to be ineffective and associated with higher mortality. A potential reason was that the greater number of cases on the West Coast provided clinicians with more information about the risks and benefits of both drugs. have 2 sons, 1 daughter, and 8 grandchildren-all of whom live out of state. Making time for family was always a high priority, although it was not always easy because he commuted 33 miles each way to work from Long Island. Still, he found time to coach his sons' basketball and baseball teams for 10 and 8 years, respectively. Dr. Bosl is enormously proud of all his children. His sons, like him, played sports: Both sons played college basketball, and 1 is a triathlete. He and his wife also enjoy traveling and have hiked in areas ranging from Alaska to Italy's Amalfi Coast. He is not through at MSKCC, either: In July 2019, he was named MSKCC ombudsman. The position was designed to provide a confidential pathway for staff to discuss potential conflict-of-interest issues, although many also come to him seeking advice on both career and workplace politics. Advising others who are just beginning their medical careers seems an appropriate way to wrap up his own. "If I had an overarching trio in my life, it was faith, my family, and MSKCC," he says. Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: a COVID-19 and Cancer Consortium (CCC19) cohort study Multivariate analysis of prognostic variables in patients with metastatic testicular cancer A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors Isochromosome of the short arm of chromosome 12: clinically useful markers for male germ cell tumors Leukemic differentiation of a mediastinal germ cell tumor Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer Increased plasma renin and aldosterone in patients treated with cisplatin-based chemotherapy for metastatic germ-cell tumors Gonadal dysfunction in patients treated for metastatic germ cell tumors Research Shows Racial Disparity, Mortality Data for Patients With Cancer